SILICON IRON (ZINC, BORON) CONTAINING GLYCEROHYDROGEL FOR TOPICAL USE, HAVING HEMOSTATIC AND ANTIMICROBIAL ACTIVITY (OPTIONS) Russian patent published in 2023 - IPC A61K31/295 A61K31/69 A61K31/695 A61K31/315 A61P7/04 A61P17/02 A61P31/04 A61P31/10 

FIELD: medicine.

SUBSTANCE: group of inventions relates to variants of silicon-iron-containing, silicon-iron-zinc-containing, silicon-iron-boron-containing and silicon-iron-zincboron-containing glycerohydrogels for topical use, having hemostatic and antimicrobial activity. Silicon-iron-containing glycerohydrogel composition Si(C₃H₇O₃)₄ ⋅ kFeC₃H₅O₃ ⋅ xC₃H₈O₃ ⋅ yH₂O, where k is greater than or equal to 0.25, but less than or equal to 0.50, x is greater than or equal to 3.00, but less than or equal to 8.00, y is greater than or equal to 24.00, but less than or equal to 28.00; silicon-iron-zinc-containing glycerohydrogel composition Si(C₃H₇O₃)₄ ⋅ kFeC₃H₅O₃ ⋅ lZnC₃H₆O₃ ⋅ xC₃H₈O₃ ⋅ yH₂O, where k is greater than or equal to 0.25, but less than or equal to 0.50; l is greater than or equal to 0.25, but less than or equal to 0.50; x is greater than or equal to 4.50 but less than or equal to 11.00; y is greater than or equal to 24.00, but less than or equal to 28.00; silicon-iron-boron-containing glycerohydrogel composition Si(C₃H₇O₃)₄ ⋅ kFeC₃H₅O₃ ⋅ mHB(C₃H₆O₃)₂ ⋅ xC₃H₈O₃ ⋅ yH₂O, where k is greater than or equal to 0.25, but less than or equal to 0.50; m is greater than or equal to 0.50, but less than or equal to 1.00; x is greater than or equal to 3.00 but less than or equal to 8.00; y - greater than or equal to 24.00, but less than or equal to 28.00; silicon-iron-zincboron-containing glycerohydrogel composition Si(C₃H₇O₃)₄ ⋅ kFeC₃H₅O₃ ⋅ lZnC₃H₆O₃ ⋅ mHB(C₃H₆O₃)₂ ⋅ xC₃H₈O₃ ⋅ yH₂O, where k is greater than or equal to 0.25, but less than or equal to 0.50; l is greater than or equal to 0.25, but less than or equal to 0.50; m is greater than or equal to 0.50, but less than or equal to 1.00; x is greater than or equal to 4.50 but less than or equal to 11.00; y is greater than or equal to 24.00 but less than or equal to 28.00.

EFFECT: group of inventions described above makes it possible to expand the arsenal of drugs with hemostatic and antimicrobial activity.

4 cl, 3 tbl, 13 ex